Cristina Ortega Duran: Evinnova clinical trial platform and how it supports oncology for toxicity monitoring in a novel patient-centric way

Cristina Ortega Duran, President/CEO of Evinova, shared on LinkedIn:

“I grew up in Madrid but Barcelona has unique elements that make it extra special… the beautiful seaside, the Sagrada Familia, and of course ESMO – European Society for Medical Oncology!

I am so excited to be there and see many of you face to face. My diary is filling up quickly, with interest in our Evinnova clinical trial platform and how it supports oncology for toxicity monitoring in a novel patient-centric way, examples CRS, ILD, Stomatitis, GI, Ocular, etc.

Please reach out, if you would like to meet up and get a demo together, or a glass of vino. E …vino…va a ESMO – European Society for Medical Oncology.”

Read further.
Source: Cristina Ortega Duran/LinkedIn